In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Correction
Oct 4, 2004
Latest in Clinical News
AI-enabled CCTA on par with IVUS for plaque quantification
November 14, 2024
New PET tracer shows promise in patients with kidney cancer
November 14, 2024
Batch reading of DBT exams leads to reader performance boost
November 12, 2024